Hany Omar

Hany Omar

University of Sharjah

H-index: 37

Asia-United Arab Emirates

About Hany Omar

Hany Omar, With an exceptional h-index of 37 and a recent h-index of 31 (since 2020), a distinguished researcher at University of Sharjah, specializes in the field of Pharmacology, Molecular Pharmacology, Cancer Research.

His recent articles reflect a diverse array of research interests and contributions to the field:

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in …

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the …

Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

Autophagy inhibition potentiates energy restriction‐induced cell death in hepatocellular carcinoma cells

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the …

New 1,2,3-triazole/1,2,4-triazole hybrids linked to oxime moiety as nitric oxide donor selective COX-2, aromatase, B-RAFV600E and EGFR inhibitors celecoxib …

Promising drug candidates for the treatment of polycystic ovary syndrome (PCOS) as alternatives to the classical medication metformin

Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: II. Antidepressant Effect in an Experimental Animal Model

Hany Omar Information

University

University of Sharjah

Position

Associate Professor College of Pharmacy and Beni-Suef University (on leave)

Citations(all)

4027

Citations(since 2020)

3103

Cited By

1997

hIndex(all)

37

hIndex(since 2020)

31

i10Index(all)

83

i10Index(since 2020)

71

Email

University Profile Page

University of Sharjah

Hany Omar Skills & Research Interests

Pharmacology

Molecular Pharmacology

Cancer Research

Top articles of Hany Omar

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in …

Authors

GBD

Journal

The Lancet

Published Date

2024

BackgroundDetailed, comprehensive, and timely reporting on population health by underlying causes of disability and premature death is crucial to understanding and responding to complex patterns of disease and injury burden over time and across age groups, sexes, and locations. The availability of disease burden estimates can promote evidence-based interventions that enable public health researchers, policy makers, and other professionals to implement strategies that can mitigate diseases. It can also facilitate more rigorous monitoring of progress towards national and international health targets, such as the Sustainable Development Goals. For three decades, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) has filled that need. A global network of collaborators contributed to the production of GBD 2021 by providing, reviewing, and analysing all available data. GBD estimates are …

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the …

Authors

Mohsen Naghavi,Kanyin Liane Ong,Amirali Aali,Hazim S Ababneh,Yohannes Habtegiorgis Abate,Cristiana Abbafati,Rouzbeh Abbasgholizadeh,Mohammadreza Abbasian,Mohsen Abbasi-Kangevari,Hedayat Abbastabar,Samar Abd ElHafeez,Michael Abdelmasseh,Sherief Abd-Elsalam,Ahmed Abdelwahab,Mohammad Abdollahi,Mohammad-Amin Abdollahifar,Meriem Abdoun,Deldar Morad Abdulah,Auwal Abdullahi,Mesfin Abebe,Samrawit Shawel Abebe,Aidin Abedi,Kedir Hussein Abegaz,ES Abhilash,Hassan Abidi,Olumide Abiodun,Richard Gyan Aboagye,Hassan Abolhassani,Meysam Abolmaali,Mohamed Abouzid,Girma Beressa Aboye,Lucas Guimarães Abreu,Woldu Aberhe Abrha,Dariush Abtahi,Samir Abu Rumeileh,Hasan Abualruz,Bilyaminu Abubakar,Eman Abu-Gharbieh,Niveen ME Abu-Rmeileh,Salahdein Aburuz,Ahmed Abu-Zaid,Manfred Mario Kokou Accrombessi,Tadele Girum Adal,Abdu A Adamu,Isaac Yeboah Addo,Giovanni Addolorato,Akindele Olupelumi Adebiyi,Victor Adekanmbi,Abiola Victor Adepoju,Charles Oluwaseun Adetunji,Juliana Bunmi Adetunji,Temitayo Esther Adeyeoluwa,Daniel Adedayo Adeyinka,Olorunsola Israel Adeyomoye,Biruk Adie Adie Admass,Qorinah Estiningtyas Sakilah Adnani,Saryia Adra,Aanuoluwapo Adeyimika Afolabi,Muhammad Sohail Afzal,Saira Afzal,Suneth Buddhika Agampodi,Pradyumna Agasthi,Manik Aggarwal,Shahin Aghamiri,Feleke Doyore Agide,Antonella Agodi,Anurag Agrawal,Williams Agyemang-Duah,Bright Opoku Ahinkorah,Aqeel Ahmad,Danish Ahmad,Firdos Ahmad,Muayyad M Ahmad,Sajjad Ahmad,Shahzaib Ahmad,Tauseef Ahmad,Keivan Ahmadi,Amir Mahmoud Ahmadzade,Ali Ahmed,Ayman Ahmed,Haroon Ahmed,Luai A Ahmed,Mehrunnisha Sharif Ahmed,Meqdad Saleh Ahmed,Muktar Beshir Ahmed,Syed Anees Ahmed,Marjan Ajami,Budi Aji,Essona Matatom Akara,Hossein Akbarialiabad,Karolina Akinosoglou,Tomi Akinyemiju,Mohammed Ahmed Akkaif,Samuel Akyirem,Hanadi Al Hamad,Syed Mahfuz Al Hasan,Fares Alahdab,Samer O Alalalmeh,Tariq A Alalwan,Ziyad Al-Aly,Khurshid Alam,Manjurul Alam,Noore Alam,Rasmieh Mustafa Al-amer,Fahad Mashhour Alanezi,Turki M Alanzi,Sayer Al-Azzam,Almaza Albakri,Mohammed Albashtawy,Mohammad T AlBataineh,Jacqueline Elizabeth Alcalde-Rabanal,Khalifah A Aldawsari,Wafa A Aldhaleei,Robert W Aldridge,Haileselasie Berhane Alema,Mulubirhan Assefa Alemayohu,Sharifullah Alemi,Yihun Mulugeta Alemu,Adel Ali Saeed Al-Gheethi,Khalid F Alhabib,Fadwa Alhalaiqa Naji Alhalaiqa,Mohammed Khaled Al-Hanawi,Abid Ali,Amjad Ali,Liaqat Ali,Mohammed Usman Ali,Rafat Ali,Shahid Ali,Syed Shujait Shujait Ali,Gianfranco Alicandro,Sheikh Mohammad Alif,Reyhaneh Alikhani,Yousef Alimohamadi,Ahmednur Adem Aliyi,Mohammad AM Aljasir,Syed Mohamed Aljunid,François Alla,Peter Allebeck,Sabah Al-Marwani,Sadeq Ali Ali Al-Maweri,Joseph Uy Almazan,Hesham M Al-Mekhlafi,Louay Almidani,Omar Almidani,Mahmoud A Alomari,Basem Al-Omari,Jordi Alonso,Jaber S Alqahtani,Shehabaldin Alqalyoobi,Ahmed Yaseen Alqutaibi

Journal

The Lancet

Published Date

2024/4/3

BackgroundRegular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations.MethodsThe Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational …

Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

Authors

Global Burden Of Disease

Journal

The Lancet

Published Date

2024

BackgroundAccurate assessments of current and future fertility—including overall trends and changing population age structures across countries and regions—are essential to help plan for the profound social, economic, environmental, and geopolitical challenges that these changes will bring. Estimates and projections of fertility are necessary to inform policies involving resource and health-care needs, labour supply, education, gender equality, and family planning and support. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 produced up-to-date and comprehensive demographic assessments of key fertility indicators at global, regional, and national levels from 1950 to 2021 and forecast fertility metrics to 2100 based on a reference scenario and key policy-dependent alternative scenarios.MethodsTo estimate fertility indicators from 1950 to 2021, mixed-effects regression models and …

Autophagy inhibition potentiates energy restriction‐induced cell death in hepatocellular carcinoma cells

Authors

Sara M Elgendy,Dana M Zaher,Nadin H Sarg,Nour N Abu Jayab,Dima W Alhamad,Taleb H Al‐Tel,Hany A Omar

Journal

IUBMB life

Published Date

2024/3/18

Hepatocellular carcinoma (HCC) significantly contributes to cancer‐related mortality due to the limited response of HCC to current anticancer therapies, thereby necessitating more effective treatment approaches. Energy restriction mimetic agents (ERMAs) have emerged as potential therapies in targeting the Warburg effect, a unique metabolic process in cancer cells. However, ERMAs exhibit limited efficacy when used as monotherapy. Additionally, ERMAs have been found to induce autophagy in cancer cells. The role of autophagy in cancer survival remains a subject of debate. Thus, it is crucial to ascertain whether ERMA‐induced autophagy is a mechanism for cell survival or cell death in HCC. Our study aims to investigate the effect of autophagy inhibition on the survival of HCC cells treated with ERMAs while also examining the potential of combining an autophagy inhibitor such as spautin‐1 with ERMAs to …

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the …

Authors

Austin E Schumacher,Hmwe Hmwe Kyu,Amirali Aali,Cristiana Abbafati,Jaffar Abbas,Rouzbeh Abbasgholizadeh,Madineh Akram Abbasi,Mohammadreza Abbasian,Samar Abd ElHafeez,Michael Abdelmasseh,Sherief Abd-Elsalam,Ahmed Abdelwahab,Mohammad Abdollahi,Meriem Abdoun,Auwal Abdullahi,Ame Mehadi Abdurehman,Mesfin Abebe,Aidin Abedi,Armita Abedi,Tadesse M Abegaz,Roberto Ariel Abeldaño Zuñiga,ES Abhilash,Olugbenga Olusola Abiodun,Richard Gyan Aboagye,Hassan Abolhassani,Mohamed Abouzid,Lucas Guimarães Abreu,Woldu Aberhe Abrha,Michael RM Abrigo,Dariush Abtahi,Samir Abu Rumeileh,Niveen ME Abu-Rmeileh,Salahdein Aburuz,Ahmed Abu-Zaid,Juan Manuel Acuna,Tim Adair,Isaac Yeboah Addo,Oladimeji M Adebayo,Oyelola A Adegboye,Victor Adekanmbi,Bashir Aden,Abiola Victor Adepoju,Charles Oluwaseun Adetunji,Temitayo Esther Adeyeoluwa,Olorunsola Israel Adeyomoye,Rishan Adha,Amin Adibi,Wirawan Adikusuma,Qorinah Estiningtyas Sakilah Adnani,Saryia Adra,Abel Afework,Aanuoluwapo Adeyimika Afolabi,Ali Afraz,Shadi Afyouni,Saira Afzal,Pradyumna Agasthi,Shahin Aghamiri,Antonella Agodi,Williams Agyemang-Duah,Bright Opoku Ahinkorah,Aqeel Ahmad,Danish Ahmad,Firdos Ahmad,Muayyad M Ahmad,Tauseef Ahmad,Keivan Ahmadi,Amir Mahmoud Ahmadzade,Mohadese Ahmadzade,Ayman Ahmed,Haroon Ahmed,Luai A Ahmed,Muktar Beshir Ahmed,Syed Anees Ahmed,Marjan Ajami,Budi Aji,Olufemi Ajumobi,Gizachew Taddesse Akalu,Essona Matatom Akara,Karolina Akinosoglou,Sreelatha Akkala,Samuel Akyirem,Hanadi Al Hamad,Syed Mahfuz Al Hasan,Ammar Al Homsi,Mohammad Al Qadire,Moein Ala,Timothy Olukunle Aladelusi,Tareq Mohammed Ali AL-Ahdal,Samer O Alalalmeh,Ziyad Al-Aly,Khurshid Alam,Manjurul Alam,Zufishan Alam,Rasmieh Mustafa Al-amer,Fahad Mashhour Alanezi,Turki M Alanzi,Mohammed Albashtawy,Mohammad T AlBataineh,Robert W Aldridge,Sharifullah Alemi,Ayman Al-Eyadhy,Adel Ali Saeed Al-Gheethi,Khalid F Alhabib,Fadwa Alhalaiqa Naji Alhalaiqa,Mohammed Khaled Al-Hanawi,Abid Ali,Akhtar Ali,Beriwan Abdulqadir Ali,Hassam Ali,Mohammed Usman Ali,Rafat Ali,Syed Shujait Shujait Ali,Zahid Ali,Shohreh Alian Samakkhah,Gianfranco Alicandro,Sheikh Mohammad Alif,Mohammad Aligol,Rasoul Alimi,Ahmednur Adem Aliyi,Adel Al-Jumaily,Syed Mohamed Aljunid,Wael Almahmeed,Sabah Al-Marwani,Sadeq Ali Ali Al-Maweri,Joseph Uy Almazan,Hesham M Al-Mekhlafi,Omar Almidani,Mahmoud A Alomari,Nivaldo Alonso,Jaber S Alqahtani,Ahmed Yaseen Alqutaibi,Salman Khalifah Al-Sabah,Awais Altaf,Jaffar A Al-Tawfiq,Khalid A Altirkawi,Farrukh Jawad Alvi,Hassan Alwafi,Yaser Mohammed Al-Worafi,Hany Aly,Karem H Alzoubi,Azmeraw T Amare,Edward Kwabena Ameyaw,Abebe Feyissa Amhare,Tarek Tawfik Amin,Alireza Amindarolzarbi,Javad Aminian Dehkordi,Sohrab Amiri,Hubert Amu,Dickson A Amugsi,Jimoh Amzat

Journal

The Lancet

Published Date

2024/3/11

BackgroundEstimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 countries and territories and 811 additional subnational locations from 1950 to 2021, with a particular emphasis on changes in mortality and life expectancy that occurred during the 2020–21 COVID-19 pandemic period.Methods22 223 data sources from vital registration, sample registration, surveys, censuses, and other sources were used to estimate mortality, with a subset of these sources used exclusively to estimate excess mortality due to the COVID-19 …

New 1,2,3-triazole/1,2,4-triazole hybrids linked to oxime moiety as nitric oxide donor selective COX-2, aromatase, B-RAFV600E and EGFR inhibitors celecoxib …

Authors

Wael AA Fadaly,Mohamed TM Nemr,Taha H Zidan,Fatma EA Mohamed,Marwa M Abdelhakeem,Nour N Abu Jayab,Hany A Omar,Khaled RA Abdellatif

Journal

Journal of Enzyme Inhibition and Medicinal Chemistry

Published Date

2023/12/31

A new series of bis-triazole 19a-l was synthesised for the purpose of being hybrid molecules with both anti-inflammatory and anti-cancer activities and assessed for cell cycle arrest, NO release. Compounds 19c, 19f, 19h, 19 l exhibited COX-2 selectivity indexes in the range of 18.48 to 49.38 compared to celecoxib S.I. = 21.10), inhibit MCF-7 with IC50 = 9–16 μM compared to tamoxifen (IC50 = 27.9 μM). and showed good inhibitory activity against HEP-3B with IC50 = 4.5–14 μM compared to sorafenib (IC50 = 3.5 μM) (HEP-3B). Moreover, derivatives 19e, 19j, 19k, 19 l inhibit HCT-116 with IC50 = 5.3–13.7 μM compared to 5-FU with IC50 = 4.8 μM (HCT-116). Compounds 19c, 19f, 19h, 19 l showed excellent inhibitory activity against A549 with IC50 = 3–4.5 μM compared to 5-FU with IC50 = 6 μM (A549). Compounds 19c, 19f, 19h, 19 l inhibit aromatase (IC50 of 22.40, 23.20, 22.70, 30.30 μM), EGFR (IC …

Promising drug candidates for the treatment of polycystic ovary syndrome (PCOS) as alternatives to the classical medication metformin

Authors

Hanan S Anbar,Nisha Yarifbhai Vahora,Hajra laghman Shah,Mariyam Mohammed Azam,Tamanna Islam,Fatima Hersi,Hany A Omar,Wolfgang Dohle,Barry VL Potter,Mohammed I El-Gamal

Journal

European Journal of Pharmacology

Published Date

2023/12/5

Polycystic ovary syndrome (PCOS) is a prevalent hormonal disorder that affects women of reproductive age. It is characterized by abnormal production of androgens, typically present in small quantities in females. This study aimed to investigate the therapeutic potential of Irosustat (STX64), STX140, and compound 1G as new drug candidates for the treatment of letrozole-induced PCOS in female Wistar rats. 36 rats were divided into six groups of equal size. PCOS was induced in all groups, except the normal control group, by administering letrozole orally (1 mg/kg/day for 35 days). The onset of abnormal estrous cycle was confirmed by examining daily vaginal smears under a microscope. Subsequently, each rat group was assigned to a different treatment regimen, including one control group, one letrozole group, one metformin group (500 mg/kg/day) as a reference drug, and the other groups received a different …

Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: II. Antidepressant Effect in an Experimental Animal Model

Authors

8 and Hussein M. Eid Mohammed H. Elkomy 1,*,Fatma I. Abo El-Ela 2,Randa Mohammed Zaki 3,4,Omar A. Alsaidan 1,Mohammed Elmowafy 1,Ameeduzzafar Zafar 1,Khaled Shalaby 1,Mohamed A. Abdelgawad 5,Hany A. Omar 6,Rania Salama 7

Journal

pharmaceutics1

Published Date

2023

Depression is a serious mental disorder and the most prevalent cause of disability and suicide worldwide. Quercetin (QER) demonstrated antidepressant effects in rats exhibiting anxiety and depressive-like behaviors. In an attempt to improve QER’s antidepressant activity, a QER-loaded transferosome (QER-TFS) thermosensitive gel for intranasal administration was formulated and optimized. The therapeutic effectiveness of the optimized formulation was assessed in a depressed rat model by conducting a behavioral analysis. Behavioral study criteria such as immobility, swimming, climbing, sucrose intake, number of crossed lines, rearing, active interaction, and latency to feed were all considerably enhanced by intranasal treatment with the QER-TFS in situ gel in contrast to other formulations. A nasal histopathological study indicated that the QER-TFS thermosensitive gel was safe for the nasal mucosa. An immunohistochemical analysis showed that the animals treated with the QER-TFS thermosensitive gel had the lowest levels of c-fos protein expression, and brain histopathological changes in the depressed rats were alleviated. According to pharmacodynamic, immunohistochemical, and histopathological experiments, the intranasal administration of the QER-TFS thermosensitive gel substantially alleviated depressive symptoms in rats. However, extensive preclinical investigations in higher animal models are needed to anticipate its effectiveness in humans.

Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19

Authors

Fatema Hersi,Anusha Sebastian,Hamadeh Tarazi,Vunnam Srinivasulu,Ahmed Mostafa,Abdou Kamal Allayeh,Cong Zeng,Ibrahim Y Hachim,Shan-Lu Liu,Imad A Abu-Yousef,Amin F Majdalawieh,Dana M Zaher,Hany A Omar,Taleb H Al-Tel

Journal

European Journal of Medicinal Chemistry

Published Date

2023/4/17

The recent emergence of different SARS-CoV-2 variants creates an urgent need to develop more effective therapeutic agents to prevent COVID-19 outbreaks. Among SARS-CoV-2 essential proteases is papain-like protease (SARS-CoV-2 PLpro), which plays multiple roles in regulating SARS-CoV-2 viral spread and innate immunity such as deubiquitinating and deISG15ylating (interferon-induced gene 15) activities. Many studies are currently focused on targeting this protease to tackle SARS-CoV-2 infection. In this context, we performed a phenotypic screening using an in-house pilot compounds collection possessing a diverse skeleta against SARS-CoV-2 PLpro. This screen identified SIMR3030 as a potent inhibitor of SARS-CoV-2. SIMR3030 has been shown to exhibit deubiquitinating activity and inhibition of SARS-CoV-2 specific gene expression (ORF1b and Spike) in infected host cells and possessing …

Gelatin nanofibers: Recent insights in synthesis, bio-medical applications and limitations

Authors

Hesham R El-Seedi,Noha S Said,Nermeen Yosri,Hamada B Hawash,Dina M El-Sherif,Mohamed Abouzid,Mohamed M Abdel-Daim,Mohammed Yaseen,Hany Omar,Qiyang Shou,Nour F Attia,Xiaobo Zou,Zhiming Guo,Shaden AM Khalifa

Published Date

2023/5/13

The use of gelatin and gelatin-blend polymers as environmentally safe polymers to synthesis electrospun nanofibers, has caused a revolution in the biomedical field. The development of efficient nanofibers has played a significant role in drug delivery, and for use in advanced scaffolds in regenerative medicine. Gelatin is an exceptional biopolymer, which is highly versatile, despite variations in the processing technology. The electrospinning process is an efficient technique for the manufacture of gelatin electrospun nanofibers (GNFs), as it is simple, efficient, and cost-effective. GNFs have higher porosity with large surface area and biocompatibility, despite that there are some drawbacks. These drawbacks include rapid degradation, poor mechanical strength, and complete dissolution, which limits the use of gelatin electrospun nanofibers in this form for biomedicine. Thus, these fibers need to be cross-linked, in order …

Targeting aldehyde dehydrogenase enzymes in combination with chemotherapy and immunotherapy: An approach to tackle resistance in cancer cells

Authors

Salma A Al-Shamma,Dana M Zaher,Fatema Hersi,Nour N Abu Jayab,Hany A Omar

Published Date

2023/5/1

Modern cancer chemotherapy originated in the 1940s, and since then, many chemotherapeutic agents have been developed. However, most of these agents show limited response in patients due to innate and acquired resistance to therapy, which leads to the development of multi-drug resistance to different treatment modalities, leading to cancer recurrence and, eventually, patient death. One of the crucial players in inducing chemotherapy resistance is the aldehyde dehydrogenase (ALDH) enzyme. ALDH is overexpressed in chemotherapy-resistant cancer cells, which detoxifies the generated toxic aldehydes from chemotherapy, preventing the formation of reactive oxygen species and, thus, inhibiting the induction of oxidative stress and the stimulation of DNA damage and cell death. This review discusses the mechanisms of chemotherapy resistance in cancer cells promoted by ALDH. In addition, we provide …

Phthalazone tethered 1, 2, 3-triazole conjugates: In silico molecular docking studies, synthesis, in vitro antiproliferative, and kinase inhibitory activities

Authors

Mohamed A Abdelgawad,Syed Nasir Abbas Bukhari,Arafa Musa,Mohammed Elmowafy,AbdElAziz A Nayl,Ahmed H El‐Ghorab,Mohamed Sadek Abdel-Bakky,Hany A Omar,Nasser Hadal Alotaibi,Hossam M Hassan,Mohammed M Ghoneim,Rania B Bakr

Journal

Bioorganic Chemistry

Published Date

2023/4/1

New phthalazone tethered 1,2,3-triazole derivatives 12–21 were synthesized utilizing the Cu(I)-catalyzed click reactions of alkyne-functionalized phthalazone 1 with functionalized azides 2–11. The new phthalazone-1,2,3-triazoles structures 12–21 were confirmed by different spectroscopic tools, like IR; 1H, 13C, 2D HMBC and 2D ROESY NMR; EI MS, and elemental analysis. The antiproliferative efficacy of the molecular hybrids 12–21 against four cancer cell lines was evaluated, including colorectal cancer, hepatoblastoma, prostate cancer, breast adenocarcinoma, and the normal cell line WI38. The antiproliferative assessment of derivatives 12–21 showed potent activity of compounds 16, 18, and 21 compared to the anticancer drug doxorubicin. Compound 16 showed selectivity (SI) towardthe tested cell lines ranging from 3.35 to 8.84 when compared to Dox., that showed SI ranged from 0.75 to 1.61. Derivatives …

Nature-inspired anticancer and antibacterial motifs and pharmaceutical composition thereof

Published Date

2022/3/29

There is provided novel anticancer and antibacterial com pounds, pharmaceutically acceptable salts thereof, and pro cesses for their preparation. The compounds have anticancer activity, which results in the reduction of tumour cell pro liferation, enhances cancers cells apoptosis and regulation of iron signalling. The compounds are also particularly active against various Gram-negative and Gram-positive multi drug-resistant bacteria, such as extended-spectrum beta lactamase (ESBL) producing and colistin-resistant Escheri chia coli, carbapenem-resistant E. coli, carbapenem resistant Acinetobacter baumannii, and methicillin-resistant

Practical solutions for improving the suboptimal performance of construction projects using Dubai construction projects as an example

Authors

Hany Omar,Lamine Mahdjoubi

Journal

Engineering, Construction and Architectural Management

Published Date

2022/2/25

PurposePoor performance remains a challenge for the construction industry worldwide. One of the key performance indicators of the construction industry is the timely delivery of projects. Despite the recent methodological and technological advances in the field, project-overrun remains a significant challenge for the industry. This paper seeks to propose practical solutions that allow overcoming the challenges and promote the opportunities for improving the performance of the construction projects in Dubai.

Antibacterial activity of small molecules which eradicate methicillin-resistant Staphylococcus aureus persisters

Authors

Mohamad Hamad,Farah Al-Marzooq,Vunnam Srinivasulu,Hany A Omar,Ashna Sulaiman,Dana M Zaher,Gorka Orive,Taleb H Al-Tel

Journal

Frontiers in microbiology

Published Date

2022/2/1

The serious challenge posed by multidrug-resistant bacterial infections with concomitant treatment failure and high mortality rates presents an urgent threat to the global health. We herein report the discovery of a new class of potent antimicrobial compounds that are highly effective against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The compounds were efficiently synthesized in one-pot employing a cascade of Groebke–Blackburn–Bienaymé and aza-Michael addition reactions. Phenotypic screening of the pilot library against various bacterial species including methicillin-sensitive and MRSA strains, has identified potent chemotypes with minimal inhibitory concentrations (MIC) of 3.125–6.25 μg/ml. The most potent compounds were fast-acting at eradicating exponentially growing MRSA, with killing achieved after 30 min of exposure to the compounds. They were also able to kill MRSA persister cells which are tolerant to most available medications. Microscopic analysis using fluorescence microscope and atomic force microscope indicate that these compounds lead to disruption of bacterial cell envelopes. Most notably, bacterial resistance toward these compounds was not observed after 20 serial passages in stark contrast to the significant resistance developed rapidly upon exposure to a clinically relevant antibiotic. Furthermore, the compounds did not induce significant hemolysis to human red blood cells. In vivo safety studies revealed a high safety profile of these motifs. These small molecules hold a promise for further studies and development as new antibacterial agents against MRSA infections.

Impact of the ACE2 activator xanthenone on tacrolimus nephrotoxicity: Modulation of uric acid/ERK/p38 MAPK and Nrf2/SOD3/GCLC signaling pathways

Authors

Amany A Azouz,Hany A Omar,Fatema Hersi,Fares EM Ali,Asmaa Mohammed M Hussein Elkelawy

Journal

Life Sciences

Published Date

2022/1/1

AimsThe calcineurin inhibitor tacrolimus is an effective and widely used immunosuppressant after organ transplantation to reduce graft rejection. However, its nephrotoxic effect could compel the patients to treatment discontinuation. The beneficial effects of angiotensin-converting enzyme 2 (ACE2) on the kidney and other organs have been investigated in several studies, but its role in tacrolimus nephrotoxicity still needs to be elucidated. Our study was designed to investigate effects of the ACE2 activator xanthenone on tacrolimus-induced renal injury.Materials and methodsMale Wistar rats were administered xanthenone (2 mg/kg) concurrently with tacrolimus (1 mg/kg) for 3 weeks, then blood and kidney tissue samples were collected for biochemical and molecular investigations.Key findingsCo-administration of xanthenone significantly improved renal functions in tacrolimus-treated rats, where serum creatinine …

The protective role of etoricoxib against diethylnitrosamine/2-acetylaminofluorene-induced hepatocarcinogenesis in Wistar rats: The impact of NF-κB/COX-2/PGE2 signaling

Authors

Gaber Ali,Hany Omar,Fatema Hersi,Amira Abo-Youssef,Osama Ahmed,Wafaa Mohamed

Journal

Current Molecular Pharmacology

Published Date

2022/1/1

Background Liver cancer ranks as the 7th and 5th leading cause of cancer morbidity worldwide in men and women, respectively. Hepatocellular Carcinoma (HCC) is the most common type of liver cancer and is associated with an increasing global burden of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH). Objective The present study aimed to investigate the possible chemopreventive effect of etoricoxib on diethylnitrosamine (DENA) and 2-acetylaminofluorene (2AAF)-induced HCC in male Wistar rats. Methods HCC was induced by DENA (150 mg/kg/week; i.p) for 2 weeks, then 2AAF (20 mg/kg; p.o) every other day for three successive weeks. Etoricoxib (0.6 mg/kg, p.o.) was given to DENA/ 2AAF-administered rats for 20 weeks. Results Etoricoxib significantly suppressed alpha-fetoprotein (AFP) and carbohydrate antigen 19-9 (CA19.9) as liver tumor biomarkers. It also …

Multi-omics analysis revealed a significant alteration of critical metabolic pathways due to sorafenib-resistance in Hep3B cell lines

Authors

Kholoud YI Abushawish,Sameh SM Soliman,Alexander D Giddey,Hamza M Al-Hroub,Muath Mousa,Karem H Alzoubi,Waseem El-Huneidi,Eman Abu-Gharbieh,Hany A Omar,Sara M Elgendy,Yasser Bustanji,Nelson C Soares,Mohammad H Semreen

Journal

International Journal of Molecular Sciences

Published Date

2022/10/9

Hepatocellular carcinoma (HCC) is the second prominent cause of cancer-associated death worldwide. Usually, HCC is diagnosed in advanced stages, wherein sorafenib, a multiple target tyrosine kinase inhibitor, is used as the first line of treatment. Unfortunately, resistance to sorafenib is usually encountered within six months of treatment. Therefore, there is a critical need to identify the underlying reasons for drug resistance. In the present study, we investigated the proteomic and metabolomics alterations accompanying sorafenib resistance in hepatocellular carcinoma Hep3B cells by employing ultra-high-performance liquid chromatography quadrupole time of flight mass spectrometry (UHPLC-QTOF-MS). The Bruker Human Metabolome Database (HMDB) library was used to identify the differentially abundant metabolites through MetaboScape 4.0 software (Bruker). For protein annotation and identification, the Uniprot proteome for Homo sapiens (Human) database was utilized through MaxQuant. The results revealed that 27 metabolites and 18 proteins were significantly dysregulated due to sorafenib resistance in Hep3B cells compared to the parental phenotype. D-alanine, L-proline, o-tyrosine, succinic acid and phosphatidylcholine (PC, 16:0/16:0) were among the significantly altered metabolites. Ubiquitin carboxyl-terminal hydrolase isozyme L1, mitochondrial superoxide dismutase, UDP-glucose-6-dehydrogenase, sorbitol dehydrogenase and calpain small subunit 1 were among the significantly altered proteins. The findings revealed that resistant Hep3B cells demonstrated significant alterations in amino acid and nucleotide metabolic …

Optimum inhibition of MCF-7 breast cancer cells by efficient targeting of the macropinocytosis using optimized paclitaxel-loaded nanoparticles

Authors

Razan B Al-Humaidi,Bahgat Fayed,Sarra B Shakartalla,Jayalakshmi Jagal,Manju N Jayakumar,Zainab M Al Shareef,Suleiman I Sharif,Ayman Noreddin,Mohammad H Semreen,Hany A Omar,Mohamed Haider,Sameh SM Soliman

Journal

Life Sciences

Published Date

2022/9/15

AimsBreast cancer (BC) is the third leading cause of death among other cancer types. Worldwide, it is the most common harmful disease in women, representing 1/4 of all cancers. Treatment of BC remains an ongoing challenge to most researchers. Understanding how cancer cells differ from normal cells can enhance drug targeting and overall disease progression. Endocytosis is a major physiological process modified in cancer cells and affects the cellular uptake of chemotherapeutic agents. MCF-7 breast cancer cells exhibit constitutive macropinocytic activity in comparison to normal non-macropinocytic MCF-10A breast cells. Therefore, we hypothesized that blocking the macropinocytosis mechanism in MCF-7 cells may inhibit the cancer progression while maintaining the safety of normal cells.Main methodsUsing nano-precipitation technique, paclitaxel-PLGA-NPs were successfully prepared in the size range …

New sulfamethoxazole derivatives as selective carbonic anhydrase ix and xii inhibitors: Design, synthesis, cytotoxic activity and molecular modeling

Authors

Mohamed A Abdelgawad,Syed NA Bukhari,Arafa Musa,Mohammed Elmowafy,Mohammed H Elkomy,AbdElAziz A Nayl,Ahmed H El-Ghorab,Ibrahim Hotan Alsohaimi,Mohamed Sadek Abdel-Bakky,Ibrahim O Althobaiti,Hamud A Altaleb,Hany A Omar,Ahmed H Abdelazeem,Mohamed A Zaki,Mohamed E Shaker,Heba AH Elshemy

Journal

Pharmaceuticals

Published Date

2022/9/10

In this study new sulphamethoxazole derivatives (S1–S4, S6–S12, and S14–S22) were designed and synthesized and their structures were fully characterized and validated using NMR, mass, and IR spectroscopy, as well as elemental analyses. All new derivatives (S1–S22) were assayed against human carbonic anhydrase (hCAs IX and XII) for their inhibitory activities. hCAs IX and XII were chosen due to the fact that CAIX expression is recognized as a hypoxia marker with a poor prognosis in breast cancer. When compared to Dorzolamide HCl as a standard reference, derivatives S2, S3, S8, S9, and S15 had the most effective inhibition with low IC50 values. The active compounds were further evaluated against hCAs I and II inhibitory activity and compounds S8, S9 and S15 showed the least inhibitory effect compared to the reference standard, acetazolamide, indicating that their effect in normal cells is the lowest. Cell viability tests for the selected compounds were carried out on MCF7 (normoxia and hypoxia) and on the normal breast cell line (MCF10a) with Staurosporine as a standard. The results showed that compound S15 had a highly potent cytotoxic effect. Furthermore, cell cycle analysis results showed that compound S15 triggered cell cycle arrest and apoptosis in G1/S of MCF7 cancer cells. Finally, molecular docking was performed to point out the possible explanation for the vital structural features and key-interactions exerted by our ligands with hCAs IX and XII that might share additional designs and highlight possible leads for a hopeful anticancer agent. Consequently, sulphamethoxazole Derivative S15 could be the potential lead …

See List of Professors in Hany Omar University(University of Sharjah)

Hany Omar FAQs

What is Hany Omar's h-index at University of Sharjah?

The h-index of Hany Omar has been 31 since 2020 and 37 in total.

What are Hany Omar's top articles?

The articles with the titles of

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in …

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the …

Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

Autophagy inhibition potentiates energy restriction‐induced cell death in hepatocellular carcinoma cells

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the …

New 1,2,3-triazole/1,2,4-triazole hybrids linked to oxime moiety as nitric oxide donor selective COX-2, aromatase, B-RAFV600E and EGFR inhibitors celecoxib …

Promising drug candidates for the treatment of polycystic ovary syndrome (PCOS) as alternatives to the classical medication metformin

Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: II. Antidepressant Effect in an Experimental Animal Model

...

are the top articles of Hany Omar at University of Sharjah.

What are Hany Omar's research interests?

The research interests of Hany Omar are: Pharmacology, Molecular Pharmacology, Cancer Research

What is Hany Omar's total number of citations?

Hany Omar has 4,027 citations in total.

    academic-engine

    Useful Links